Argenx
ARGX
#418
Rank
$56.09 B
Marketcap
$900.76
Share price
-0.05%
Change (1 day)
47.42%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report